Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026)
Azenta's (AZTA) quarterly Non-Current Deferred Tax Liability came in at $15.7 million in Q1 2026, down 29.43% year-on-year from $22.3 million in Q1 2025, and up 3.27% on a QoQ basis from $15.2 million in Q4 2025.
Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
Azenta (AZTA) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $15.7 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 29.43% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $15.7 million, a 29.43% decrease from a year earlier, with the FY2025 full-year figure at $15.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $15.7 million, up from $15.2 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for AZTA reached as high as $85.9 million in Q4 2022 and fell as low as $2.9 million in Q2 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $39.7 million across 5 years, with a median of $22.3 million in 2025.
- Across the five-year window, Non-Current Deferred Tax Liability slumped 95.59% in 2024 and jumped 600.76% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $85.9 million in 2022, then declined by 23.31% to $65.9 million in 2023, then sank by 71.2% to $19.0 million in 2024, then fell by 19.62% to $15.2 million in 2025, then rose by 3.27% to $15.7 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $15.7 million in Q1 2026, $15.2 million in Q4 2025, and $18.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 62.27 Mn |
| Mar 31, 2024 | 62.27 Mn |
| Dec 31, 2023 | 65.87 Mn |
| Dec 31, 2023 | 65.87 Mn |